Rivastigmine improves hippocampal neurogenesis and depression-like behaviors via 5-HT1A receptor stimulation in olfactory bulbectomized mice

MR Islam, S Moriguchi, H Tagashira, K Fukunaga - Neuroscience, 2014 - Elsevier
Rivastigmine is a non-competitive inhibitor of both acetylcholinesterase (AChE) and
butylcholinesterase (BuChE) used to treat mild to moderate dementia in Alzheimer's disease …
被引用次数：57 相关文章

Rivastigmine improves hippocampal neurogenesis and depression-like behaviors via 5-HT1A receptor stimulation in olfactory bulbectomized mice.

MR Islam, S Moriguchi, H Tagashira, K Fukunaga - Neuroscience, 2014 - europepmc.org
Rivastigmine is a non-competitive inhibitor of both acetylcholinesterase (AChE) and
butylcholinesterase (BuChE) used to treat mild to moderate dementia in Alzheimer's disease …

[引用][C] Rivastigmine improves hippocampal neurogenesis and depression-like behaviors via 5-HT1A receptor stimulation in olfactory bulbectomized mice

MR Islam, S Moriguchi, H Tagashira, K Fukunaga - Neuroscience, 2014 - cir.nii.ac.jp
Rivastigmine improves hippocampal neurogenesis and depression-like behaviors via 5-HT1A
receptor stimulation in olfactory bulbectomized mice | CiNii Research CiNii 国立情報学研究所 …

Rivastigmine improves hippocampal neurogenesis and depression-like behaviors via 5-HT1A receptor stimulation in olfactory bulbectomized mice

MR Islam, S Moriguchi, H Tagashira… - …, 2014 - ibroneuroscience.org
Rivastigmine is a non-competitive inhibitor of both acetylcholinesterase (AChE) and
butylcholinesterase (BuChE) used to treat mild to moderate dementia in Alzheimer's disease …

Rivastigmine improves hippocampal neurogenesis and depression-like behaviors via 5-HT1A receptor stimulation in olfactory bulbectomized mice

MR Islam, S Moriguchi, H Tagashira… - …, 2014 - tohoku.elsevierpure.com
Rivastigmine is a non-competitive inhibitor of both acetylcholinesterase (AChE) and
butylcholinesterase (BuChE) used to treat mild to moderate dementia in Alzheimer's disease …

Rivastigmine improves hippocampal neurogenesis and depression-like behaviors via 5-HT1A receptor stimulation in olfactory bulbectomized mice

MR Islam, S Moriguchi, H Tagashira, K Fukunaga - Neuroscience, 2014 - infona.pl
Rivastigmine is a non-competitive inhibitor of both acetylcholinesterase (AChE) and
butylcholinesterase (BuChE) used to treat mild to moderate dementia in Alzheimer's disease …

Rivastigmine improves hippocampal neurogenesis and depression-like behaviors via 5-HT1A receptor stimulation in olfactory bulbectomized mice

MR Islam, S Moriguchi, H Tagashira… - …, 2014 - pubmed.ncbi.nlm.nih.gov
Rivastigmine is a non-competitive inhibitor of both acetylcholinesterase (AChE) and
butylcholinesterase (BuChE) used to treat mild to moderate dementia in Alzheimer's disease …

[引用][C] RIVASTIGMINE IMPROVES HIPPOCAMPAL NEUROGENESIS AND DEPRESSION-LIKE BEHAVIORS VIA 5-HT 1A RECEPTOR STIMULATION IN …

MR ISLAM, S MORIGUCHI, H TAGASHIRA… - …, 2014 - pascal-francis.inist.fr
RIVASTIGMINE IMPROVES HIPPOCAMPAL NEUROGENESIS AND DEPRESSION-LIKE
BEHAVIORS VIA 5-HT 1A RECEPTOR STIMULATION IN OLFACTORY BULBECTOMIZED …

[引用][C] RIVASTIGMINE IMPROVES HIPPOCAMPAL NEUROGENESIS AND DEPRESSION-LIKE BEHAVIORS VIA 5-HT 1A RECEPTOR STIMULATION IN …

MR ISLAM, S MORIGUCHI, H TAGASHIRA… - Neuroscience, 2014 - Elsevier